Aktienanalyse zu American Vanguard Corporation (AVD)AVDAmerican Vanguard Corporation

American Vanguard Corporation is a diversified specialty and agriculture products company, which develops and markets products for crop protection and management, turf and ornamentals management, and public and animal health. It conducts its business through its operating subsidiaries, including AMVAC Chemical Corporation (AMVAC) for its domestic business and AMVAC Netherlands BV (AMVAC BV) for its international business. AMVAC is a manufacturer of chemical, biological and biorational products that develops and markets solutions for agricultural, commercial and consumer uses. It synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection. These products, which include insecticides, fungicides, and biorationals, are marketed in liquid, powder, and granular forms. AMVAC BV sells products both directly and through its network of subsidiaries in various international territories. It operates in the Industrials sector (AGRICULTURAL CHEMICALS industry).

American Vanguard Corp (AVD) is not a good buy right now due to its current price of 1.03, a very low RSI of 16.965 indicating oversold conditions, and a staggering year-to-date change of -72.97%. The company has been consistently reporting negative net income, with the latest quarterly net income at -9,868,000 USD. The main risk is its high debt-to-equity ratio of 147.54%, indicating significant leverage that could affect financial stability.

4 analysts cover AVD: 3 rate it Buy, 1 Hold and 0 Sell.